KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ARGS
Delisted

Argos Therapeutics Fund Price (Quote)

$0.0536
+0 (+0%)
At Close: Apr 15, 2020

Range Low Price High Price Comment
30 days $0.0536 $0.0536 Wednesday, 15th Apr 2020 ARGS stock ended at $0.0536. During the day the stock fluctuated 0% from a day low at $0.0536 to a day high of $0.0536.
90 days $0.0536 $0.0536
52 weeks $0.0350 $0.0840

Historical Argos Therapeutics prices

Date Open High Low Close Volume
Feb 12, 2016 $82.60 $82.60 $82.60 $82.60 4 740
Feb 11, 2016 $79.20 $79.20 $79.20 $79.20 7 305
Feb 10, 2016 $79.20 $79.20 $79.20 $79.20 15 800
Feb 09, 2016 $90.60 $90.60 $90.60 $90.60 39 880
Feb 08, 2016 $76.40 $76.40 $76.40 $76.40 23 725
Feb 05, 2016 $62.80 $62.80 $62.80 $62.80 4 525
Feb 04, 2016 $61.00 $61.00 $61.00 $61.00 3 545
Feb 03, 2016 $59.20 $59.20 $59.20 $59.20 5 050
Feb 02, 2016 $61.60 $61.60 $61.60 $61.60 9 650
Feb 01, 2016 $64.60 $64.60 $64.60 $64.60 16 405
Jan 29, 2016 $54.00 $54.00 $54.00 $54.00 5 610
Jan 28, 2016 $53.40 $53.40 $53.40 $53.40 6 290
Jan 27, 2016 $58.40 $58.40 $58.40 $58.40 19 215
Jan 26, 2016 $66.60 $66.60 $66.60 $66.60 40 165
Jan 25, 2016 $49.00 $49.00 $49.00 $49.00 2 925
Jan 22, 2016 $52.20 $52.20 $52.20 $52.20 4 335
Jan 21, 2016 $48.20 $48.20 $48.20 $48.20 5 170
Jan 20, 2016 $46.00 $46.00 $46.00 $46.00 1 715
Jan 19, 2016 $43.20 $43.20 $43.20 $43.20 1 645
Jan 15, 2016 $39.80 $39.80 $39.80 $39.80 1 020
Jan 14, 2016 $38.80 $38.80 $38.80 $38.80 1 985
Jan 13, 2016 $39.40 $39.40 $39.40 $39.40 4 815
Jan 12, 2016 $45.40 $45.40 $45.40 $45.40 3 985
Jan 11, 2016 $45.80 $45.80 $45.80 $45.80 3 775
Jan 08, 2016 $44.80 $44.80 $44.80 $44.80 2 325
Click to get the best stock tips daily for free!

About Argos Therapeutics

Argos Therapeutics, Inc. focuses on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases in North America. The company develops immunotherapies based on Arcelis, its proprietary technology platform. Its development stage products include AGS-003, which is under Phase III clinical trials for the treatment of metastatic renal cell carcinoma and other cancers; and AGS-004, which ... ARGS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT